Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
XELIRI regimen plus continuous treatment with bevacizumab is well-tolerated and effective in metastatic colorectal cancer patients in a second-line setting involving the sequential administration of XELOX and XELIRI.
Suzuki K, Takaharu K, Muto Y, Ichida K, Fukui T, Takayama Y, Tsujinaka S, Sasaki J, Horie H, Kawamura YJ, Konishi F, Rikiyama T. Suzuki K, et al. Among authors: rikiyama t. Mol Clin Oncol. 2014 Sep;2(5):827-832. doi: 10.3892/mco.2014.306. Epub 2014 Jun 6. Mol Clin Oncol. 2014. PMID: 25054053 Free PMC article.
Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized.
Kato T, Suzuki K, Muto Y, Sasaki J, Tsujinaka S, Kawamura YJ, Noda H, Horie H, Konishi F, Rikiyama T. Kato T, et al. Among authors: rikiyama t. World J Surg Oncol. 2015 Feb 7;13:23. doi: 10.1186/s12957-014-0432-2. World J Surg Oncol. 2015. PMID: 25889477 Free PMC article.
Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
Muto Y, Suzuki K, Kato T, Tsujinaka S, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Saito M, Futsuhara K, Noda H, Miyakura Y, Konishi F, Rikiyama T. Muto Y, et al. Among authors: rikiyama t. Int J Oncol. 2016 Sep;49(3):1057-67. doi: 10.3892/ijo.2016.3583. Epub 2016 Jun 17. Int J Oncol. 2016. PMID: 27315529
Clinical characteristics of synchronous colorectal cancers in Japan.
Kato T, Alonso S, Muto Y, Noda H, Miyakura Y, Suzuki K, Tsujinaka S, Saito M, Perucho M, Rikiyama T. Kato T, et al. Among authors: rikiyama t. World J Surg Oncol. 2016 Oct 24;14(1):272. doi: 10.1186/s12957-016-1027-x. World J Surg Oncol. 2016. PMID: 27776528 Free PMC article.
Clinical and molecular assessment of regorafenib monotherapy.
Kakizawa N, Suzuki K, Fukui T, Takayama Y, Ichida K, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Rikiyama T. Kakizawa N, et al. Among authors: rikiyama t. Oncol Rep. 2017 Apr;37(4):2506-2512. doi: 10.3892/or.2017.5456. Epub 2017 Feb 15. Oncol Rep. 2017. PMID: 28259999
171 results